Johnson & Johnson (JNJ) Shares Outstanding (Weighted Average) (2009 - 2026)

Johnson & Johnson's Shares Outstanding (Weighted Average) history runs 18 years deep, the most recent figure standing at $2.4 billion for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) changed 0.06% year-over-year to $2.4 billion; the TTM figure through Mar 2026 stood at $2.4 billion (changed 0.06% YoY), while the FY2025 annual figure was $2.4 billion, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) came in at $2.4 billion for Q1 2026 at Johnson & Johnson, roughly flat from $2.4 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $2.6 billion in Q1 2022 to a low of $2.4 billion in Q2 2025.
• A 5-year average of $2.5 billion and a median of $2.5 billion in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) dropped 7.57% in 2024 and grew 0.06% in 2026, its largest moves.
• Johnson & Johnson's Shares Outstanding (Weighted Average) stood at $2.6 billion in 2022, then retreated by 3.59% to $2.5 billion in 2023, then slipped by 4.98% to $2.4 billion in 2024, then gained by 0.0% to $2.4 billion in 2025, then gained by 0.05% to $2.4 billion in 2026.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $2.4 billion, $2.4 billion, and $2.4 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison